Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
Sponsor: Boehringer Ingelheim
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3031185 in healthy male subjects following administration of multiple rising doses.
Official title: Safety, Tolerability, and Pharmacokinetics of Multiple Rising Oral Doses of BI 3031185 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design)
Key Details
Gender
MALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-04-07
Completion Date
2026-11-02
Last Updated
2026-02-17
Healthy Volunteers
Yes
Conditions
Interventions
BI 3031185
BI 3031185
Midazolam
Midazolam
Placebo
Placebo matching BI 3031185
Locations (1)
Charité Research Organisation GmbH
Berlin, Germany